Morphology of chemical immunosuppression.
D000477:Alkylating Agents / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000970:Antineoplastic Agents / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000628:therapy; D001666:Binding Sites, Antibody; D004798:Enzymes / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D007154:Immune System Diseases; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007239:Infections / Q000188:drug therapy; D008938:Mitosis / Q000187:drug effects; D008967:Molecular Biology; D009173:Mycophenolic Acid / Q000494:pharmacology; D009369:Neoplasms / Q000628:therapy; D009607:Nitrosourea Compounds / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011714:Pyrans / Q000494:pharmacology; D014184:Transplantation, Homologous
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D004798:Enzymes; D006728:Hormones; D006834:Hydrazines; D007166:Immunosuppressive Agents; D009607:Nitrosourea Compounds; D011714:Pyrans; D009173:Mycophenolic Acid; D011070:Poly I-C